Thursday, April 16, 2026

A Recent Milestone in HIV Treatment: The 10th Patient

By: Jonathan Sosa, Guest Blog Contributor, ADAP Advocacy

Recently, a Norwegian man became the 10th person ever to be cured of HIV. It represents another step forward in understanding how long-term remission can be achieved for those living with HIV. The news also still offers hope for people living with HIV/AIDS (PLWHA) that a cure is possible, while also offering some good news for the HIV community–which has been battered by a presidential administration gutting long-established and proven safety-net programs that have served as the backbone of the nation’s care continuum for them.


HIV cell being destroyed
Photo Source: Live Science | Dr_Microbe via Getty Images

The 63-year-old Norwegian patient received a stem cell transplant from his brother, who carries a rare genetic mutation known as CCR5-delta 32. This mutation prevents HIV from entering immune cells, effectively blocking the virus from spreading within the body. 


Following the transplant, the patient discontinued antiretroviral therapy (ART) and has shown no detectable viral load (Glassman-Hughes, 2026; Gometz, 2026). While cases like this are rare, they prove that eliminating HIV from the body is possible nonetheless. 


Limits of this treatment approach 


Despite the significance of this case, there are limitations that prevent it from being a universal solution for curing HIV/AIDS. 


First, stem cell transplants are complex, high-risk procedures usually done on patients who have cancer. In other words, these are not common procedures (or even the safest options) for most PLWHA. 


Second, the 10th man cured from HIV/AIDS has a brother with a natural mutation that creates a natural resistance to it. However, there are not many donors that may have this CCR5 mutation, which limits the ability to scale this approach to others living with HIV/AIDS. Due to limitations like these, researchers are not viewing this case as a universal solution but as insight into how the disease can be cured in more people moving forward. 


HIV Vaccine
Photo Source: WowRx

Why HIV/AIDS funding matters 


The HIV community has expressed concern with feeling under attack, since policies regarding funding are being called into question, and in some cases gutted or eliminated as proposed in the Trump Administration’s Fiscal Year 2027 budget blueprint. This uncertainty makes continued scientific progress even more important. It shows why HIV funding matters. 


Despite pressures on HIV advocacy and proposed funding cuts, there is still promising news, like the cure for the 'Oslo patient'. Each new case is evidence that a cure to HIV is possible. Prior to this case, several other HIV patients who underwent comparable transplants had achieved long-term remission from the infection (Lanese, 2026).


Continued progress in HIV treatment is driven by ongoing research efforts to find a cure. According to the National Institutes of Health, current strategies include gene-editing techniques designed to replicate the CCR5 mutation, immune-based therapies targeting hidden viral reservoirs, and approaches aimed at activating and eliminating latent viral reservoirs within the body (National Institutes of Health, 2026). 

These research efforts reinforce why continued investment in HIV research remains essential for providing accessible care. Although challenges remain, progress is being made, and cases like these prove why research and investment into HIV care should be supported.


Disclaimer: All of the funders of the ADAP Advocacy Association are publicly available online at https://www.adapadvocacy.org/support.html. 


Disclaimer: Guest blogs do not necessarily reflect the views of the ADAP Advocacy Association; rather, they provide a neutral platform for the author to promote open, honest discussion of public health-related issues and updates.

References:

[1] Lanese, Nicoletta. (2026, April 13). Oslo patient likely cured of HIV after getting stem cell transplant from his brother who is genetically resistant to the virus. Live Science. https://www.livescience.com/health/hiv/oslo-patient-likely-cured-of-hiv-after-getting-stem-cell-transplant-from-his-brother-who-is-genetically-resistant-to-the-virus

[2] National Institutes of Health. (2025, April 15). Research toward an HIV cure: Research priorities overview. NIH Office of AIDS Research. https://www.oar.nih.gov/hiv-policy-and-research/research-priorities-overview/research-toward-hiv-cure

[3] Glassman-Hughes, Emma. (2026, April 14). Norwegian man is 10th person cured of HIV thanks to his brother. New York Post. https://nypost.com/2026/04/14/health/norwegian-man-is-10th-person-cured-of-hiv-thanks-to-his-brother/

[4] Gometz, Emma (2026, April 13). Person functionally cured of HIV after bone marrow transplant from sibling. Scientific American. https://www.scientificamerican.com/article/person-functionally-cured-of-hiv-after-bone-marrow-transplant-from-sibling/

No comments: